Exelixis Stock Quote
$20.12 -$0.50 -2.4%
BATS BZX Real Time Price as of August 23, 2019, 11:46 a.m. EDT View Interactive EXEL Charts

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

News & Analysis: Exelixis

The Fool has written over 400 articles on Exelixis.


Market Moves



Is Exelixis a Buy?

This biotech might be a one-trick pony for now. But it's got a great horse to ride.

3 Cancer-Treatment Stocks to Buy

These three businesses are a great way for investors to support the war on cancer.

These 3 Value Stocks Are Absurdly Cheap Right Now

You have to look hard to see value in today's pricey market, but here are three inexpensive stocks that should be on your radar today.

Exelixis Expands Its Sales

The biotech produced solid top-line growth spurred by a new approval for Cabometyx.

Interactive Chart